NCT06168123 Future Optimal Research and Care Evaluation - Aortic Stenosis
| NCT ID | NCT06168123 |
| Status | Recruiting |
| Phase | — |
| Sponsor | St. Antonius Hospital |
| Condition | Severe Aortic Valve Stenosis |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2023-11-27 |
| Primary Completion | 2027-08-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2023-11-27 with a primary completion date of 2027-08-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
In the past decade the treatment of aortic valve stenosis has rapidly changed. At first, transcatheter aortic valve implantation (TAVI) was a last resort option for inoperable patients. Nowadays, it more and more becomes an alternative to surgical aortic valve replacement (SAVR) - also in younger and lower risk patients. This poses important questions to clinical practise regarding the optimal life-time management of each individual patient. Which involves (durability of) treatment modality (surgical vs. transcatheter vs. conservative treatment) as well as the duration and type of the required antithrombotic treatment. Objective: to evaluate the effect of treatment modality (surgical vs. transcatheter vs. conservative treatment) and its complications on quality of life and survival in AoS patients.
Eligibility Criteria
Inclusion Criteria: * Older than 18 years of age * Severe or moderate aortic stenosis No exclusion criteria are applicable to this registry
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06168123 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 110 Years, studying Severe Aortic Valve Stenosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06168123 currently recruiting?
Yes, NCT06168123 is actively recruiting participants. Contact the research team at c.overduin@antoniusziekenhuis.nl for enrollment information.
Where is the NCT06168123 trial being conducted?
This trial is being conducted at Nieuwegein, Netherlands.
Who is sponsoring the NCT06168123 clinical trial?
NCT06168123 is sponsored by St. Antonius Hospital. The trial plans to enroll 800 participants.